| Literature DB >> 16216395 |
Nancy Gore Saravia1, Blanca Escorcia, Yaneth Osorio, Liliana Valderrama, Darren Brooks, Lourdes Arteaga, Graham Coombs, Jeremy Mottram, Bruno Luis Travi.
Abstract
This study demonstrates that deletion of cysteine proteinase (CP) genes diminishes pathogenicity of Leishmania mexicana in non-murine experimental host models while preserving immunogenicity. Both cpb and cpa/cpb-deficient lines induced delayed disease onset, smaller lesions and lower parasite burden in hamsters. cpa/cpb-deficient L. mexicana grew more slowly as promastigotes and presented lower infectivity and growth in human mononuclear phagocytic host cells. Protection against homologous challenge comparable to that induced by infection with the virulent wild-type (WT) L. mexicana strain was achieved in the highly susceptible hamster model by immunization with 1000 cpb-deficient promastigotes. CP-deficient L. mexicana elicited significantly lower levels of Th2-associated cytokines IL-10 and TGF-beta than the WT in the primary lesion of hamsters. These findings support the feasibility of using genetically attenuated live Leishmania to achieve protective immunity.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16216395 DOI: 10.1016/j.vaccine.2005.05.045
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641